What is Conflixis?
Founded in 2022, Conflixis provides an AI-powered platform specifically engineered for conflicts of interest (COI) management. The platform serves as a vital tool for hospitals and research institutions, moving beyond manual data entry to provide real-time analysis of internal records, government payment databases, and procurement data. By identifying high-risk financial relationships between clinicians and industry partners, the software enables organizations to proactively manage regulatory exposure and improve procurement decision-making. This enterprise-level SaaS solution is essential for entities operating under strict legal mandates, offering predictive insights that foster ethical decision-making and operational integrity.
How much funding has Conflixis raised?
Conflixis has raised a total of $4.5M across 2 funding rounds:
Other Financing Round
$275K
Angel/Seed
$4.2M
Other Financing Round (2024): $275K, investors not publicly disclosed
Angel/Seed (2024): $4.2M led by Lerer Hippeau Ventures, Origin Ventures, and SpringTime Ventures
Key Investors in Conflixis
Lerer Hippeau Ventures
Lerer Hippeau is a venture capital firm focused on investing in innovative startups, particularly in the early stages such as Seed and Pre-Seed rounds. They aim to support founders with great ideas who are willing to tackle challenging problems, fostering long-term success through their expertise as former operators.
Origin Ventures
Origin Ventures is an early-stage venture capital firm that invests in bold founders and innovative companies transforming productivity and automation through artificial intelligence. Their portfolio includes a range of sectors such as electrification, labor automation, commerce, and AI-native software.
SpringTime Ventures
SpringTime Ventures is a seed stage investment firm that focuses on high-growth startups primarily in the healthcare, fintech, logistics, and marketplace sectors across the USA. They support entrepreneurs with a commitment to building trusting relationships and providing ongoing support post-funding.
What's next for Conflixis?
With this major strategic investment, Conflixis is well-positioned to accelerate its product development and expand its footprint within the healthcare enterprise market. The company's focus on automating compliance workflows addresses a significant pain point in the industry, where the cost of regulatory non-compliance continues to rise. Moving forward, the firm is expected to scale its operations, potentially integrating deeper predictive analytics to further refine its risk-detection capabilities. As healthcare systems continue to prioritize digital transformation, Conflixis is poised to become a standard-bearer for transparency and automated governance in clinical and research environments.
See full Conflixis company page
